Expanding youth-friendly HPV vaccination services for girls in Nigeria
Research Project 1
This project uses youth-led ideas and community methods to make it easier for girls aged 9–15 in Nigeria to get the HPV vaccine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11177749 on NIH RePORTER |
What this research studies
You would be invited to help shape and use new, youth-friendly ways to get the HPV vaccine in your community. The team works with young people as partners using youth participatory action methods, local cultural models (PEN-3), and implementation science to design solutions that fit local needs. They will run open calls and designathons (crowdsourcing) and offer apprenticeships so youths and community members create and promote vaccination options. The program aims to bring vaccines closer to schools and neighborhoods to reduce barriers like low awareness, limited social support, and poor access.
Who could benefit from this research
Good fit: Girls aged 9–15 in the Nigerian communities targeted by the program, as well as parents, teachers, and youth leaders who support them, are ideal participants.
Not a fit: People outside the 9–15 age range, those not living in participating communities, or those already fully vaccinated are unlikely to directly benefit from this project.
Why it matters
Potential benefit: If successful, this could increase HPV vaccination among Nigerian girls and reduce future HPV-related cancers.
How similar studies have performed: Community-driven and youth-led approaches, including crowdsourcing, have shown promise in improving vaccine uptake in some settings but are still emerging and being tested in Nigeria.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Iwelunmor, Juliet — Washington University
- Study coordinator: Iwelunmor, Juliet
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.